

| 規格 | 價格 | 會員價 | 庫存 | 數量 | ||||
|---|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} | 咨詢 | 咨詢 |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 現貨 1周 咨詢 | - + |
快速發貨 順豐冷鏈運輸,1-2 天到達
品質保證
技術支持
免費溶解

| 產品名稱 | 5-alpha Reductase ↓ ↑ | 其他靶點 | 純度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dutasteride | ? | 99% | |||||||||||||||||
| Finasteride |
+++
5-α reductase, Ki: 10.2 nM |
98% | |||||||||||||||||
| 1. 鼠標懸停在“+”上可以顯示相關IC50的具體數值。"+"越多,抑制作用越強。2. "?"表示該化合物對相應的亞型有抑制作用,但抑制強度暫時沒有相關數據。 | |||||||||||||||||||
| 產品名稱 | Dehydrogenase ↓ ↑ | 其他靶點 | 純度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trilostane | ? | 99+% | |||||||||||||||||
| AGI-6780 |
+++
IDH2 R140Q mutant, IC50: 23 nM |
99%+ | |||||||||||||||||
| Gimeracil | ? | 98% | |||||||||||||||||
| AGI-5198 |
++
R132C-IDH1, IC50: 0.16 μM R132H-IDH1, IC50: 70 nM |
99%+ | |||||||||||||||||
| SW033291 |
++++
15-PGDH, IC50: 1.5 nM 15-PGDH, Ki: 0.1 nM |
99%+ | |||||||||||||||||
| Mycophenolic acid | ? | 99+% | |||||||||||||||||
| Fomepizole | ? | 98% | |||||||||||||||||
| Leflunomide | ? | 98% | |||||||||||||||||
| 3-Nitropropanoic acid | ? | 99%+ | |||||||||||||||||
| Isovaleramide | ? | 99% | |||||||||||||||||
| Mycophenolate Mofetil |
+++
Inosine monophosphate dehydrogenase II, IC50: 27 nM Inosine monophosphate dehydrogenase I, IC50: 39 nM |
98% | |||||||||||||||||
| MK-8245 |
++++
SCD1 (rat), IC50: 3 nM SCD1 (mouse), IC50: 1 nM |
99%+ | |||||||||||||||||
| Vidofludimus |
++
Human DHODH, IC50: 134 nM |
99%+ | |||||||||||||||||
| Emodin | ? | 98% | |||||||||||||||||
| Ivosidenib | ? | 98% | |||||||||||||||||
| NCT-501 |
++
ALDH1A1, IC50: 40 nM |
98% | |||||||||||||||||
| Gossypol | ? | 99%+ | |||||||||||||||||
| Devimistat | ? | 98% | |||||||||||||||||
| Disulfiram | ? | 98%+ | |||||||||||||||||
| Enasidenib |
++++
IDH2, IC50: 12 nM |
98% | |||||||||||||||||
| PluriSIn 1 | ? | 99%+ | |||||||||||||||||
| ML390 |
+
DHODH, IC50: 0.56 μM |
99%+ | |||||||||||||||||
| Teriflunomide | ? | 99%+ | |||||||||||||||||
| Daidzin |
+++
ALDH-Ⅰ, Ki: 20 nM |
98+% | |||||||||||||||||
| 18β-Glycyrrhetinic acid | ? | 99% | |||||||||||||||||
| RRx-001 | ? | 95% | |||||||||||||||||
| NCT-503 |
+
PHGDH, IC50: 2.5 μM |
99%+ | |||||||||||||||||
| Vorasidenib | ? | 99%+ | |||||||||||||||||
| Ammonium Glycyrrhizinate(x:1) | ? | 98+% | |||||||||||||||||
| 1. 鼠標懸停在“+”上可以顯示相關IC50的具體數值。"+"越多,抑制作用越強。2. "?"表示該化合物對相應的亞型有抑制作用,但抑制強度暫時沒有相關數據。 | |||||||||||||||||||
| 產品名稱 | NF-κB ↓ ↑ | 其他靶點 | 純度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammonium pyrrolidine-1-carbodithioate | ? | 98% | |||||||||||||||||
| QNZ |
++++
NF-κB, IC50: 11 nM |
99%+ | |||||||||||||||||
| Sodium 4-Aminosalicylate Dihydrate | ? | 98% | |||||||||||||||||
| Sodium Salicylate | ? | 95% | |||||||||||||||||
| Parthenolide | ? | p53 | 97% HPLC | ||||||||||||||||
| JSH-23 |
+
NF-κB, IC50: 7.1 μM |
98% | |||||||||||||||||
| Phenethyl caffeate | ? | 98% (E) | |||||||||||||||||
| Andrographolide | ? | 98+% | |||||||||||||||||
| Curcumin | ? | Nrf2,HDAC | 98% | ||||||||||||||||
| SC75741 |
+++
NF-κB, EC50: 200 nM |
99%+ | |||||||||||||||||
| CBL0137 HCl |
++
NF-κB, EC50: 0.47 μM |
p53 | 99%+ | ||||||||||||||||
| 1. 鼠標懸停在“+”上可以顯示相關IC50的具體數值。"+"越多,抑制作用越強。2. "?"表示該化合物對相應的亞型有抑制作用,但抑制強度暫時沒有相關數據。 | |||||||||||||||||||
| 描述 | Germacrone, a natural product isolated and purified from the rhizoma of Curcuma wenyujin with anti-tumor activity, can inhibit the proliferation of breast cancer cell lines by inducing cell cycle arrest and apoptosis through mitochondria-mediated caspase pathway, and may be a potent chemopreventive drug candidate for liver cancer via regulating the expression of proteins related to G2/M cell cycle and apoptosis, and p53 and oxidative damage may play important roles in the inhibition of human hepatoma cells growth by germacrone. |
| Concentration | Treated Time | Description | References | |
| Differentiated HepaRG cells | 100 μM | 1, 6, 12, 24 hours | To evaluate the effect of Germacrone on reactive oxygen species (ROS) production in HepaRG cells, results showed that Germacrone significantly increased ROS production at 100 μM. | Nutrients. 2020 Jun 8;12(6):1720. |
| Differentiated HepaRG cells | 250 μM | 24 hours | To evaluate the effect of Germacrone on the viability of HepaRG cells, results showed that Germacrone significantly inhibited cell viability at 250 μM. | Nutrients. 2020 Jun 8;12(6):1720. |
| LO2 cells | 10-40 μM | 12 hours | GER protects hepatocytes by inhibiting APAP-induced mitochondrial ROS release | Front Pharmacol. 2021 Oct 5;12:745561. |
| LX-2 cells | 60-120 μM | 24 hours | GER promotes HSC apoptosis by upregulating cleaved-caspase 3 protein expression and inhibiting anti-apoptotic protein Bcl-2 expression | Front Pharmacol. 2021 Oct 5;12:745561. |
| GES-1 cells | 7.89% | 24, 48, 72 hours | To investigate the effect of Germacrone on the proliferation of GES-1 cells, results showed that high concentrations ( ≥90μg/mL) of zedoary oil killed GES-1 cells. | Chin Med. 2013 Jun 28;8:13. |
| MGC 803 cells | 7.89% | 24, 48, 72 hours | To investigate the effect of Germacrone on the proliferation of MGC 803 cells, results showed that zedoary oil significantly decreased the cell viability of MGC 803 cells. | Chin Med. 2013 Jun 28;8:13. |
| AGS cells | 7.89% | 24, 48, 72 hours | To investigate the effect of Germacrone on the proliferation of AGS cells, results showed that zedoary oil significantly decreased the cell viability of AGS cells. | Chin Med. 2013 Jun 28;8:13. |
| IEC-6 cells | 1, 2, 4 μM | 24 hours | Germacrone significantly upregulated the mRNA expression of HO-1 and NQO1 in IEC-6 cells and significantly increased the mRNA expression of ZO-1 and Occludin to alleviate ethanol-induced intestinal barrier injury. | Front Pharmacol. 2022 Sep 26;13:981706. |
| HepG2 cells | 0.5, 1, 2 μM | 24 hours | Germacrone significantly downregulated the mRNA transcription of NQO1 in HepG2 cells, and GM-H reduced the expression of HO-1, while the protein expression of HO-1 showed a similar trend. | Front Pharmacol. 2022 Sep 26;13:981706. |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague-Dawley rats | Adjuvant-induced arthritis (AIA) rat model | Tail vein injection | 8 mg/kg GER | Administered on days 16, 18, 20, 22, and 24 | Evaluate the therapeutic effect of FA-NPs/GER in AIA rats, results showed that FA-NPs/GER significantly reduced the swelling and inflammation infiltration of the rat’s foot and decreased the levels of pro-inflammatory cytokines (TNF-α, IL-1β). | Drug Deliv. 2022 Dec;29(1):692-701. |
| C57BL/6 mice | MCD diet-induced liver fibrosis model | Intragastric gavage | 25 or 50 mg/kg | Once daily for 6 weeks | GER ameliorates MCD diet-induced liver fibrosis by inhibiting the TGF-β/Smad signaling pathway | Front Pharmacol. 2021 Oct 5;12:745561. |
| 計算器 | ||||
| 存儲液制備 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.58mL 0.92mL 0.46mL |
22.90mL 4.58mL 2.29mL |
45.80mL 9.16mL 4.58mL |
|
| CAS號 | 6902-91-6 |
| 分子式 | C15H22O |
| 分子量 | 218.33 |
| SMILES Code | C/C(C)=C1C/C=C(C)/CC/C=C(C)/CC\1=O |
| MDL No. | MFCD00210050 |
| 別名 | 牻牛兒酮 ;(E,E)-Germacrone |
| 英文名稱 | (3E,7E)-3,7-Dimethyl-10-(propan-2-ylidene)cyclodeca-3,7-dien-1-one |
| 運輸 | 藍冰 |
| 存儲條件 |
In solvent -20°C: 3-6個月 -80°C: 12個月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO 中的溶解度 : 100 mg/mL (458.02 mM; 超聲助溶; 吸濕的 DMSO 對產品的溶解度有顯著影響,請使用新開封的 DMSO) 以下溶解方案都請先按照體外實驗的方式配制澄清的儲備液,再依次添加助溶劑: ——為保證實驗結果的可靠性,澄清的儲備液可以根據儲存條件,適當保存;體內實驗的工作液,建議現用現配,當天使用; 以下溶劑前顯示的百分比是指該溶劑在終溶液中的體積占比;如在配制過程中出現沉淀、析出現象,可以通過加熱和/或超聲的方式助溶
|
滬公網安備 31011002007707號
滬ICP備2025150922號-1
危化品經營許可證:滬(楊)應急管危經許[2025]204822(QY)